Curaleaf Holdings Inc
Change company Symbol lookup
Select an option...
CURLF Curaleaf Holdings Inc
BRCC BRC Inc
FSMAX Fidelity® Extended Market Index Fund
PFE Pfizer Inc
DUNE Dune Acquisition Corp
METV Roundhill Ball Metaverse ETF
TBNK Territorial Bancorp Inc
BAC Bank of America Corp
ICD Independence Contract Drilling Inc
NOK Nokia Oyj
Go

Health Care : Pharmaceuticals | Small Cap Growth
Based in Canada
Company profile

Curaleaf Holdings, Inc. is a Canada-based international provider of consumer products in the cannabis market. The Company improves lives by providing cannabis for consumption. The Company and its brands, including Curaleaf and Select, provide service, product selection and accessibility across the medical and adult-use markets. The Company operates in 23 states with 123 dispensaries and 25 cultivation sites. It focuses on populated, limited license states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York, and Pennsylvania. Curaleaf International is the vertically integrated cannabis company in Europe with a supply and distribution network throughout the European market, bringing together science and research with cultivation, extraction and production. The Company's brands also include Curaleaf Hemp and UKU Cannabis. Curaleaf is a national retail dispensary brand in the United States, which is available in multiple states and product formats.

Closing Price
$5.76
Day's Change
-0.081 (-1.39%)
Bid
--
Ask
--
B/A Size
--
Day's High
6.00
Day's Low
5.75
Volume
(Light)
Volume:
353,027

10-day average volume:
544,066
353,027

Display:

Providers:

UpdateCancel
4 providers
May 11, 2022
Here's why Curaleaf looks past headwinds and sticks to 2022 revenue view

By Steve Gelsi Curaleaf sees traction in N.J., Ill., Fla., and looks toward growth in NY, Conn., and overseas Curaleaf Holdings Inc. remains on track to generate up to $1.5 billion in revenue in 2022 -- up from $1.2 billion in 2021...(MarketWatch)

April 12, 2022
New Jersey takes step toward adult use cannabis sales

New Jersey'a Cannabis Regulatory Commission on Monday OK'd applications from seven cannabis companies to sell cannabis to adults over 21, pending operational inspections and issuance of new licenses. Acreage Holdings , Ascend Wellness Holdings...(MarketWatch)

April 04, 2022
Garden State legal cannabis licenses are taking longer than expected

By Steve Gelsi NJ is blowing past deadlines for its adult-use program as regulators seek to ensure there'll be ample supply New Jersey may be known as the Garden State, but its adult use cannabis market continues to take longer than...(MarketWatch)

March 24, 2022
Cresco Labs is buying Columbia Care in major cannabis merger that will create biggest U.S. player

By Steve Gelsi Cresco Labs is buying Columbia Care for $2.1 billion in stock in a deal that will help expand its U.S. footprint Cresco Labs Inc. CEO Charlie Bachtell said his company's $2 billion all-stock purchase of Columbia Care...(MarketWatch)

March 04, 2022
Curaleaf narrows quarterly loss and tops $1 billion in annual revenue for the first time

By Steve Gelsi CEO Joe Bayen expects 2022 to be 'a good year' for company and the cannabis industry Curaleaf Holdings Inc. reported a narrower fourth-quarter loss that was wider than Wall Street estimates, but the cannabis company...(MarketWatch)

Curaleaf stock price target cut to C$15 from C$21 at Alliance Global

(END) Dow Jones Newswires March 04, 2022 07:49 ET (12:49 GMT) (MarketWatch)

February 28, 2022
Curaleaf moves to quash rumors that executives' ties to Russia may lead to sanctions

By Steve Gelsi Cannabis company says rumors about its founder and executive chairman and another shareholder are 'incorrect' U.S. cannabis company Curaleaf has told investors that it is not subject to any sanctions against Russia...(MarketWatch)

February 25, 2022
Curaleaf started at buy with $12 stock price target at Benchmark

(END) Dow Jones Newswires February 25, 2022 06:22 ET (11:22 GMT) (MarketWatch)

February 11, 2022
Inflation has knocked back the market. Here are the key S&P 500 and tech stock levels one strategist fears.

By Barbara Kollmeyer Critical information for the U.S. trading day Investors are still trying to come to grips with that double whammy of nosebleed consumer prices and 100-basis-point increase talk from St. Louis Federal Reserve...(MarketWatch)

January 06, 2022
Tilray expected to grow sales sequentially but remain in the red

By Steve Gelsi Tilray grows its top line even as it faces a potential loss in the quarter Tilray Inc. will likely grow its sales over the previous quarter but it's expected to post a net loss when it becomes the first major cannabis...(MarketWatch)

December 22, 2021
Al Harrington-backed Village is aiming to support women- and minority-owned cannabis companies

By Steve Gelsi Village co-founder Dan Pettrigrew is helping steer the company toward growth in New York and other states coming on line with adult-use licenses With states such as New York planning to issue social equity cannabis...(MarketWatch)

December 21, 2021
Investors in cannabis companies burned by stock-market losses in 2021 even as the pot business grows

By Steve Gelsi Big federal moves on cannabis remain unlikely in 2022 even as more states go legal Cannabis companies look toward 2022 with plans to expand their businesses to legal markets in more states despite an expected lack of...(MarketWatch)

December 14, 2021
Curaleaf raises $425 million in debt

Alliance Global Securities analyst Aaron Grey said Tuesday a $425 million debt deal by Curaleaf Holdings Inc. will result in cost savings of about $20 million from lower interest payments. Grey reiterated a buy rating on Curaleaf and said...(MarketWatch)

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.